BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cirrincione LR, Senneker T, Scarsi K, Tseng A. Drug Interactions with Gender-Affirming Hormone Therapy: Focus on Antiretrovirals and Direct Acting Antivirals. Expert Opin Drug Metab Toxicol 2020;16:565-82. [PMID: 32479127 DOI: 10.1080/17425255.2020.1777278] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Le A, Huang KJ, Cirrincione LR. Regulation of drug-metabolizing enzymes by sex-related hormones: clinical implications for transgender medicine. Trends Pharmacol Sci 2022:S0165-6147(22)00056-6. [PMID: 35487786 DOI: 10.1016/j.tips.2022.03.006] [Reference Citation Analysis]
2 King EM, Prior JC, Pick N, van Schalkwyk J, Kestler M, Tkachuk S, Loutfy M, Murray MCM. Menopausal hormone therapy for women living with HIV. Lancet HIV 2021;8:e591-8. [PMID: 34384545 DOI: 10.1016/S2352-3018(21)00148-X] [Reference Citation Analysis]
3 Cirrincione LR, Huang KJ. Sex and Gender Differences in Clinical Pharmacology: Implications for Transgender Medicine. Clin Pharmacol Ther 2021;110:897-908. [DOI: 10.1002/cpt.2234] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Cirrincione LR, Huang KJ. Sex and Gender Differences in Clinical Pharmacology: Implications for Transgender Medicine. Clin Pharmacol Ther 2021;110:897-908. [PMID: 33763856 DOI: 10.1002/cpt.2234] [Cited by in F6Publishing: 1] [Reference Citation Analysis]